Europe PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical and Biotechnology Companies, and Others)
The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030. Increasing ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise. PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation. Europe PCR Technologies Market Overview The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways. Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million) Europe PCR Technologies Market Segmentation The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country. Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022. In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR. By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022. Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022. By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022. Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Europe PCR Technologies Market - Key Industry Dynamics 4.1 PCR Technologies Market - Key Industry Dynamics 4.2 Market Drivers 4.2.1 Rising Prevalence of Genetic and Infectious Diseases 4.2.2 Surging Investments and Funds Availability for PCR Technologies 4.3 Market Restraints 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays 4.4 Market Opportunities 4.4.1 Increasing Demand for POC Testing 4.5 Future Trends 4.5.1 Advancements in PCR Technologies 4.6 Impact of Drivers and Restraints: 5. PCR Technologies Market - Europe Market Analysis 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030 6. Europe PCR Technologies Market Analysis - By Technology 6.1 Overview 6.2 Real Time PCR 6.2.1 Overview 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.3 Conventional PCR 6.3.1 Overview 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.4 Reverse Transcription PCR 6.4.1 Overview 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.5 Digital PCR 6.5.1 Overview 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.6 Multiplex RT PCR 6.6.1 Overview 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.7 Hot Start PCR 6.7.1 Overview 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million) 6.8 Others 6.8.1 Overview 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million) 7. Europe PCR Technologies Market Analysis - By Offerings 7.1 Overview 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%) 7.3 Reagents and Consumables 7.3.1 Overview 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million) 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size 7.4 Instruments 7.4.1 Overview 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million) 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments 7.5 Software and Services 7.5.1 Overview 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million) 8. Europe PCR Technologies Market Analysis - By Application 8.1 Overview 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%) 8.3 Gene Expression Analysis 8.3.1 Overview 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million) 8.4 Genetic Sequencing 8.4.1 Overview 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million) 8.5 Genotyping 8.5.1 Overview 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million) 8.6 Nucleic Acid Synthesis 8.6.1 Overview 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million) 8.7 Standard Validation 8.7.1 Overview 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million) 8.8 Point of Care Diagnostics 8.8.1 Overview 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million) 8.9 Environmental Application 8.9.1 Overview 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million) 8.10 Others 8.10.1 Overview 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million) 9. Europe PCR Technologies Market Analysis - By End User 9.1 Overview 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%) 9.3 Hospitals and Diagnostic Centers 9.3.1 Overview 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million) 9.4 Academia and Research Institutes 9.4.1 Overview 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million) 9.5 Pharmaceutical and Biotechnology Companies 9.5.1 Overview 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million) 9.6 Others 9.6.1 Overview 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million) 10. Europe PCR Technologies Market -Country Analysis 10.1 Europe: PCR Technologies Market 10.1.1 Overview 10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country 10.1.2.1 Germany 10.1.2.1.1 Overview 10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology 10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings 10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments 10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size 10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application 10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User 10.1.2.3 United Kingdom 10.1.2.3.1 Overview 10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology 10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings 10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments 10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size 10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application 10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User 10.1.2.5 France 10.1.2.5.1 Overview 10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings 10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments 10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size 10.1.2.6.2 France PCR Technologies Market Breakdown by Application 10.1.2.6.3 France PCR Technologies Market Breakdown by End User 10.1.2.7 Italy 10.1.2.7.1 Overview 10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology 10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings 10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments 10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size 10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application 10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User 10.1.2.9 Spain 10.1.2.9.1 Overview 10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology 10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings 10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments 10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size 10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application 10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User 10.1.2.11 Rest of Europe 10.1.2.11.1 Overview 10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) 10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology 10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings 10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments 10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables 10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size 10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application 10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User 11. PCR Technologies Market-Industry Landscape 11.1 Overview 11.2 Growth Strategies in the PCR Technologies Market 11.3 Inorganic Growth Strategies 11.3.1 Overview 11.4 Organic Growth Strategies 11.4.1 Overview 12. Company Profiles 12.1 Thermo Fisher Scientific Inc 12.1.1 Key Facts 12.1.2 Business Description 12.1.3 Products and Services 12.1.4 Financial Overview 12.1.5 SWOT Analysis 12.1.6 Key Developments 12.2 Promega Corp 12.2.1 Key Facts 12.2.2 Business Description 12.2.3 Products and Services 12.2.4 Financial Overview 12.2.5 SWOT Analysis 12.2.6 Key Developments 12.3 QIAGEN NV 12.3.1 Key Facts 12.3.2 Business Description 12.3.3 Products and Services 12.3.4 Financial Overview 12.3.5 SWOT Analysis 12.3.6 Key Developments 12.4 bioMerieux SA 12.4.1 Key Facts 12.4.2 Business Description 12.4.3 Products and Services 12.4.4 Financial Overview 12.4.5 SWOT Analysis 12.4.6 Key Developments 12.5 Hoffmann-La Roche Ltd 12.5.1 Key Facts 12.5.2 Business Description 12.5.3 Products and Services 12.5.4 Financial Overview 12.5.5 SWOT Analysis 12.5.6 Key Developments 12.6 Bio-Rad Laboratories Inc 12.6.1 Key Facts 12.6.2 Business Description 12.6.3 Products and Services 12.6.4 Financial Overview 12.6.5 SWOT Analysis 12.6.6 Key Developments 12.7 Becton Dickinson and Co 12.7.1 Key Facts 12.7.2 Business Description 12.7.3 Products and Services 12.7.4 Financial Overview 12.7.5 SWOT Analysis 12.7.6 Key Developments 12.8 Takara Bio Inc 12.8.1 Key Facts 12.8.2 Business Description 12.8.3 Products and Services 12.8.4 Financial Overview 12.8.5 SWOT Analysis 12.8.6 Key Developments 12.9 Standard Biotools Inc 12.9.1 Key Facts 12.9.2 Business Description 12.9.3 Products and Services 12.9.4 Financial Overview 12.9.5 SWOT Analysis 12.9.6 Key Developments 12.10 Agilent Technologies Inc 12.10.1 Key Facts 12.10.2 Business Description 12.10.3 Products and Services 12.10.4 Financial Overview 12.10.5 SWOT Analysis 12.10.6 Key Developments 12.11 Ellume Ltd 12.11.1 Key Facts 12.11.2 Business Description 12.11.3 Products and Services 12.11.4 Financial Overview 12.11.5 SWOT Analysis 12.11.6 Key Developments 13. Appendix 13.1 About the Insight Partners 13.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
The Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(diagnostic)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/08 10:26 148.90 円 163.91 円 197.75 円 |